Euler Biologics
PrivateLast Round
Seed
Sep 1, 2024
Company Overview
Euler Biologics is a biotechnology company developing antibody-based therapies designed to preserve and enhance physical function for older adults.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Euler Biologics Comparables
Compare Euler Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immunis, Inc. | 81% | |
| Zoe Biosciences | 81% | |
| Deciduous Therapeutics | 73% |
Euler Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 1, 2024 |
Euler Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Seed |
| Pillar VC | Seed |
| Soma Capital | Seed |
| Axial VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2024
Seed round raised from Gaingels, Pillar VC, Soma Capital, and Axial VC.
Euler Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Euler Biologics's valuation, stock price, and market status.
Is Euler Biologics a public or private company?
Euler Biologics is a private company.
What is the current stock price of Euler Biologics?
Euler Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Euler Biologics worth (valuation)?
Valuation information for Euler Biologics is not publicly available.
Can I buy Euler Biologics stock?
Euler Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Euler Biologics's last funding round?
Euler Biologics's most recent funding round was Seed on September 1, 2024.
Who are the main investors in Euler Biologics?
Key investors in Euler Biologics include Gaingels, Pillar VC, Soma Capital, Axial VC.
Will Euler Biologics IPO soon?
No public IPO plans have been announced for Euler Biologics.
How can I track Euler Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Euler Biologics's secondary market activity and sign up for updates.